Gilead Sciences Inc (GILD.OQ)
Get access to over 18 million research reports from over 1,700 sources.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
- private equity
- third-party document and information retrieval
- and much, much more…
|65||2016||Executive Chairman of the Board|
|55||2016||President, Chief Executive Officer, Director|
|54||2014||Chief Financial Officer, Executive Vice President|
|59||2016||Chief Operating Officer|
|61||2007||Executive Vice President - Research and Development, Chief Scientific Officer|
- BRIEF-EMA Says Gilead Pulls Application To Extend Use Of Zydelig Drug
- BRIEF-Gilead Sciences Says Executive Vice President, Commercial Operations Will Retire
- Sangamo in $3 billion gene-editing deal with Gilead
- UPDATE 2-Sangamo in $3 billion gene-editing deal with Gilead
- Gilead signs $3 bln licensing deal for Sangamo's gene-editing platform